ORAL DRUGS FOR PATHOGENETIC TREATMENT OF MULTIPLE SCLEROSIS

Abstract

This article presents a review of the efficacy and safety of three oral drugs for multiple sclerosis, which are registered in the Russian Federation: teriflunomide, dimethylfumarate, fingolimod.

Keywords

• multiple sclerosis
• teriflunomide
• dimethylfumarate
• fingolimod